메뉴 건너뛰기




Volumn 217, Issue 1-2, 2004, Pages 27-31

The evolution of aldosterone antagonists

Author keywords

Aldosterone; Aldosterone antagonists; Aldosterone blockers; Eplerenone; Selectivity; Spironolactone

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; EPLERENONE; SPIRONOLACTONE; STEROID RECEPTOR;

EID: 2342592636     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.005     Document Type: Conference Paper
Times cited : (153)

References (39)
  • 1
    • 0017624810 scopus 로고
    • Effect of enoterohepatic circulation on the pharmacokinetics of spironolactone in man
    • Abshagen U., et al. Effect of enoterohepatic circulation on the pharmacokinetics of spironolactone in man. Naunyn-schmiedeberg's Arch. Pharmacol. 300:1977;281-287
    • (1977) Naunyn-schmiedeberg's Arch. Pharmacol. , vol.300 , pp. 281-287
    • Abshagen, U.1
  • 2
    • 0025675680 scopus 로고
    • Remodeling of the right and left ventricles in experimental hypertension
    • Brilla C., Pick R., Tan L., Janicki J., Weber K. Remodeling of the right and left ventricles in experimental hypertension. Circ. Res. 67:1990;1355-1364
    • (1990) Circ. Res. , vol.67 , pp. 1355-1364
    • Brilla, C.1    Pick, R.2    Tan, L.3    Janicki, J.4    Weber, K.5
  • 3
    • 0345630502 scopus 로고
    • Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion
    • Carpenter C., Davis J.O., Ayers C.R. Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion. J. Clin. Invest. 40:1961;26-2042
    • (1961) J. Clin. Invest. , vol.40 , pp. 26-2042
    • Carpenter, C.1    Davis, J.O.2    Ayers, C.R.3
  • 4
    • 0000084418 scopus 로고
    • Steroidal aldosterone blockers. II
    • Cella J., Tweit R. Steroidal aldosterone blockers. II. J. Org. Chem. 24:1959;1109-1110
    • (1959) J. Org. Chem. , vol.24 , pp. 1109-1110
    • Cella, J.1    Tweit, R.2
  • 6
    • 0036893488 scopus 로고    scopus 로고
    • Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: Differential metabolism by CYP3A and CYP3A5
    • Cook C.S., Berry L.M., Kim D.H., Burton E.G., Hribar J.D., Zhang L. Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A and CYP3A5. Drug Met. Dispos. 30:2002;1344-1351
    • (2002) Drug Met. Dispos. , vol.30 , pp. 1344-1351
    • Cook, C.S.1    Berry, L.M.2    Kim, D.H.3    Burton, E.G.4    Hribar, J.D.5    Zhang, L.6
  • 8
    • 0018098679 scopus 로고
    • SC-25152: A potent mineralocorticoid antagonist with reduced affinity for the 5α-dihydrotestosterone receptor of human and rat prostate
    • Cutler G.B., Pita J.C., Rifka S.M., Menard R.H., Sauer M.A., Loriaux D.L. SC-25152: A potent mineralocorticoid antagonist with reduced affinity for the 5α-dihydrotestosterone receptor of human and rat prostate. J. Clin. Endocrinal. Metab. 47:1978;171-175
    • (1978) J. Clin. Endocrinal. Metab. , vol.47 , pp. 171-175
    • Cutler, G.B.1    Pita, J.C.2    Rifka, S.M.3    Menard, R.H.4    Sauer, M.A.5    Loriaux, D.L.6
  • 9
    • 0018332936 scopus 로고
    • SC-25152: A potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone
    • Cutler G.B., Sauer M.A., Loriaux D.L. SC-25152: A potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone. J. Pharmacol. Exp. Ther. 209:1979;144-146
    • (1979) J. Pharmacol. Exp. Ther. , vol.209 , pp. 144-146
    • Cutler, G.B.1    Sauer, M.A.2    Loriaux, D.L.3
  • 10
    • 0017225440 scopus 로고
    • Mechanisms regulating renin release
    • Davis J.O., Freeman R.H. Mechanisms regulating renin release. Physiol. Rev. 56:1976;1-56
    • (1976) Physiol. Rev. , vol.56 , pp. 1-56
    • Davis, J.O.1    Freeman, R.H.2
  • 14
    • 0014341097 scopus 로고
    • Mode of spirolactone action: Competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors
    • Fanestil D.D. Mode of spirolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors. Biochem. Pharmacol. 17:1968;2240-2242
    • (1968) Biochem. Pharmacol. , vol.17 , pp. 2240-2242
    • Fanestil, D.D.1
  • 16
    • 0016380105 scopus 로고
    • Molecular modifications of anti-aldosterone compounds: Effects on affinity of spirolactones for renal aldosterone receptors
    • Funder J., Feldman D., Highland E., Edelman I. Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors. Biochem. Pharmacol. 23:1974;1493-1501
    • (1974) Biochem. Pharmacol. , vol.23 , pp. 1493-1501
    • Funder, J.1    Feldman, D.2    Highland, E.3    Edelman, I.4
  • 17
    • 0015912489 scopus 로고
    • Adverse reactions to spironolactone: A report from the Boston Collaborative Drug Surveillance Program
    • Greenblatt D.J., Koch-Weser J. Adverse reactions to spironolactone: a report from the Boston Collaborative Drug Surveillance Program. J. Am. Med. Assoc. 225:1973;40-43
    • (1973) J. Am. Med. Assoc. , vol.225 , pp. 40-43
    • Greenblatt, D.J.1    Koch-Weser, J.2
  • 19
    • 0014778519 scopus 로고
    • Spirolactone inhibition of aldosterone induced nuclear RNA synthesis in toad urinary bladder
    • Hutchinson J.H., Porter G.A. Spirolactone inhibition of aldosterone induced nuclear RNA synthesis in toad urinary bladder. Res. Comm. Chem. Path. Pharm. 1(3):1970;363-369
    • (1970) Res. Comm. Chem. Path. Pharm. , vol.1 , Issue.3 , pp. 363-369
    • Hutchinson, J.H.1    Porter, G.A.2
  • 20
    • 0000167622 scopus 로고
    • Action of new steroids blocking effects of aldosterone and desoxycorticosterone on salt
    • Kagawa C.M., et al. Action of new steroids blocking effects of aldosterone and desoxycorticosterone on salt. Science. 126:1957;1015-1016
    • (1957) Science , vol.126 , pp. 1015-1016
    • Kagawa, C.M.1
  • 21
    • 0018164753 scopus 로고
    • Spironolactone: Disposition, metabolism, pharmacodynamics and bioavailability
    • Karim A. Spironolactone: disposition, metabolism, pharmacodynamics and bioavailability. Drug Metab. Rev. 8(1):1978;151-188
    • (1978) Drug Metab. Rev. , vol.8 , Issue.1 , pp. 151-188
    • Karim, A.1
  • 22
    • 0036330671 scopus 로고    scopus 로고
    • Addition of eplerenone to ACE inhibition or angiotensin blockade in hypertensive patients
    • Krum H., Nolly H., Workman D., He W., Roniker B., Krause S., Fakouhi K. Addition of eplerenone to ACE inhibition or angiotensin blockade in hypertensive patients. Hypertension. 40:2002;117-123
    • (2002) Hypertension , vol.40 , pp. 117-123
    • Krum, H.1    Nolly, H.2    Workman, D.3    He, W.4    Roniker, B.5    Krause, S.6    Fakouhi, K.7
  • 24
    • 0035320408 scopus 로고    scopus 로고
    • Recent studies with eplerenone, a novel selective aldosterone receptor antagonist
    • McMahon E. Recent studies with eplerenone, a novel selective aldosterone receptor antagonist. Curr. Opin. Pharmacol. 1:2001;190-196
    • (2001) Curr. Opin. Pharmacol. , vol.1 , pp. 190-196
    • McMahon, E.1
  • 25
    • 0023512031 scopus 로고
    • The metabolism and biopharmaceutics of spironolactone in man
    • Overdiek H.W. The metabolism and biopharmaceutics of spironolactone in man. Drug Metab. Interact. 5:1987;273-302
    • (1987) Drug Metab. Interact. , vol.5 , pp. 273-302
    • Overdiek, H.W.1
  • 26
  • 30
    • 0038819295 scopus 로고
    • Protection by a steroid-spirolactone against certain types of cardiac necroses
    • Selye H. Protection by a steroid-spirolactone against certain types of cardiac necroses. Proc. Soc. Exp. Biol. Med. 104:1960;212-213
    • (1960) Proc. Soc. Exp. Biol. Med. , vol.104 , pp. 212-213
    • Selye, H.1
  • 31
    • 0011886496 scopus 로고
    • Isolierung eines neuen kristallisierten hormons aus nebennieren mit besonderer hoher wirksamkeit auf den mineralstoff wechsel
    • Simpson S.A., Tait J.F., Wettstein A., Neher R., Von Euw V.J., Reichstein T. Isolierung eines neuen kristallisierten hormons aus nebennieren mit besonderer hoher wirksamkeit auf den mineralstoff wechsel. Experientia. 9:1953;33-38
    • (1953) Experientia , vol.9 , pp. 33-38
    • Simpson, S.A.1    Tait, J.F.2    Wettstein, A.3    Neher, R.4    Von Euw, V.J.5    Reichstein, T.6
  • 32
    • 84961040686 scopus 로고
    • Prevention of adrenal-regeneration hypertension by an aldosterone-blocker
    • Sturtevant F.M. Prevention of adrenal-regeneration hypertension by an aldosterone-blocker. Endocrinology. 64:1959;299-300
    • (1959) Endocrinology , vol.64 , pp. 299-300
    • Sturtevant, F.M.1
  • 33
    • 0037016007 scopus 로고    scopus 로고
    • Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in dogs with heart failure
    • Suzuki G., Morita H., Mishima T., Sharov V.G., Todor A., Tanhehco E.J., Rudolph A.E., McMahon E.G., Goldstein S., Sabbah H.N. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation. 106:2002;2967-2972
    • (2002) Circulation , vol.106 , pp. 2967-2972
    • Suzuki, G.1    Morita, H.2    Mishima, T.3    Sharov, V.G.4    Todor, A.5    Tanhehco, E.J.6    Rudolph, A.E.7    McMahon, E.G.8    Goldstein, S.9    Sabbah, H.N.10
  • 34
    • 0141997157 scopus 로고    scopus 로고
    • Satefy, tolerability and pharmacokinetics of eplerenone, a selective aldosterone blocker
    • (abstract)
    • Tolbert D.S., Reid S.E., Roniker B. Satefy, tolerability and pharmacokinetics of eplerenone, a selective aldosterone blocker. Pharmacokinetics. 22(10):2002;1331. (abstract)
    • (2002) Pharmacokinetics , vol.22 , Issue.10 , pp. 1331
    • Tolbert, D.S.1    Reid, S.E.2    Roniker, B.3
  • 35
    • 0021889021 scopus 로고
    • Assessment of the antimineralocorticoid effect of RU 28 318 in healthy men with induced exogenous and endogenous hyper-mineralocorticism
    • Ulmann A., Bertagna C., LeGo A., Husson J.M., Tache A., Sassano P., Menard J., Corvol P. Assessment of the antimineralocorticoid effect of RU 28 318 in healthy men with induced exogenous and endogenous hyper-mineralocorticism. Eur. J. Clin. Pharmacol. 28:1985;531-535
    • (1985) Eur. J. Clin. Pharmacol. , vol.28 , pp. 531-535
    • Ulmann, A.1    Bertagna, C.2    Lego, A.3    Husson, J.M.4    Tache, A.5    Sassano, P.6    Menard, J.7    Corvol, P.8
  • 37
    • 0035997359 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in mild to moderate hypertension
    • Weinberger M., Roniker B., Krause S., Weiss R.J. Eplerenone, a selective aldosterone blocker, in mild to moderate hypertension. Am. J. Hypertens. 15(8):2002;709-716
    • (2002) Am. J. Hypertens. , vol.15 , Issue.8 , pp. 709-716
    • Weinberger, M.1    Roniker, B.2    Krause, S.3    Weiss, R.J.4
  • 38
    • 0038673178 scopus 로고    scopus 로고
    • Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension
    • White W.B., Duprez D., St. Hillaire R., Krause S., Roniker B., Juse-Hamilton J., Weber M.A. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension. 41:2003a;1021-1026
    • (2003) Hypertension , vol.41 , pp. 1021-1026
    • White, W.B.1    Duprez, D.2    St. Hillaire, R.3    Krause, S.4    Roniker, B.5    Juse-Hamilton, J.6    Weber, M.A.7
  • 39
    • 0037861923 scopus 로고    scopus 로고
    • Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension
    • White W.B., Carr A.A., Krause S., Jordan R., Roniker B., Oigman W. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. Am. J. Cardiol. 92:2003b;38-42
    • (2003) Am. J. Cardiol. , vol.92 , pp. 38-42
    • White, W.B.1    Carr, A.A.2    Krause, S.3    Jordan, R.4    Roniker, B.5    Oigman, W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.